Alivus Life Sciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 610.83 | 659.63 | 652.30 |
| Operating Expense | 429.54 | 451.11 | 451.54 |
| Net Profit | 121.54 | 141.87 | 136.96 |
| Net Profit Margin | 19.90 | 21.51 | 21.00 |
| Earning Per Share | 9.91 | 11.57 | 11.18 |
| EBIDTA | 178.79 | 206.98 | 199.39 |
| Effective Tax Rate | 21.48 | 22.96 | 23.32 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 610.83 |
| Operating Expense | 429.54 |
| Net Profit | 121.54 |
| Net Profit Margin | 19.90 |
| Earning Per Share | 9.91 |
| EBIDTA | 178.79 |
| Effective Tax Rate | 21.48 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 2,283.21 | 2,161.22 | 2,123.21 |
| Operating Expenses Annual | 1,608.97 | 1,518.93 | 1,507.15 |
| Operating Profit Annual | 686.29 | 671.25 | 630.76 |
| Interest Annual | 1.55 | 0.55 | 27.96 |
| Depreciation | 53.45 | 42.09 | 37.88 |
| Net Profit Annual | 470.89 | 466.96 | 418.72 |
| Tax Annual | 160.40 | 161.65 | 146.20 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 2,283.21 |
| Operating Expenses Annual | 1,608.97 |
| Operating Profit Annual | 686.29 |
| Interest Annual | 1.55 |
| Depreciation | 53.45 |
| Net Profit Annual | 470.89 |
| Tax Annual | 160.40 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 283.82 | 512.16 | 115.60 |
| Cash Flow from Operations | 413.52 | 306.01 | 597.59 |
| Cash Flow from Investing | -116.48 | -146.75 | -122.23 |
| Cash Flow from Financing | -279.44 | -387.59 | -78.80 |
| Cash Flow at the End | 301.41 | 283.82 | 512.16 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 283.82 |
| Cash Flow from Operations | 413.52 |
| Cash Flow from Investing | -116.48 |
| Cash Flow from Financing | -279.44 |
| Cash Flow at the End | 301.41 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 30.06 | 31.06 | 29.71 |
| PBIT Margin (%) | 27.72 | 29.11 | 27.92 |
| PBT Margin (%) | 9.84 | -23.82 | 26.92 |
| Net PROFIT Margin (%) | 20.62 | 21.61 | 19.72 |
| Return On Networth / Equity (%) | 21.07 | 22.28 | 29.83 |
| Return On Networth /Employed (%) | 27.94 | 29.80 | 42.20 |
| Return On Assets (%) | 20.83 | 22.04 | 29.78 |
| Total Debt / Equity (X) | 0.01 | 0.01 | TBA |
| Asset Turnover Ratio (%) | 1.01 | 1.02 | 1.51 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 30.06 |
| PBIT Margin (%) | 27.72 |
| PBT Margin (%) | 9.84 |
| Net PROFIT Margin (%) | 20.62 |
| Return On Networth / Equity (%) | 21.07 |
| Return On Networth /Employed (%) | 27.94 |
| Return On Assets (%) | 20.83 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 1.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 809.87 | 792.89 | 595.03 |
| Total Current Assets Annual | 1,916.00 | 1,850.34 | 1,764.58 |
| Non Current Assets Annual | 934.41 | 851.81 | 706.42 |
| Total Shareholders Funds Annual | 2,332.32 | 2,138.21 | 2,054.31 |
| Total Assets Annual | 2,850.41 | 2,702.15 | 2,471.01 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 809.87 |
| Total Current Assets Annual | 1,916.00 |
| Non Current Assets Annual | 934.41 |
| Total Shareholders Funds Annual | 2,332.32 |
| Total Assets Annual | 2,850.41 |
No Data Availabe
